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Abstract
This paper describes a new bioinformatic tool for use in psychiatric research, “SLEP” (Sullivan
Lab Evidence Project). SLEP is a searchable archive of findings from psychiatric genetics that is
freely available on the web for non-commercial use (http://slep.unc.edu). Via a simple interface,
users can retrieve findings from genomewide linkage, genomewide association, and microarray
studies for ADHD, autism, bipolar disorder, eating disorders, major depression, nicotine
dependence, and schizophrenia. Findings can be save to disk or viewed via a genome browser.
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The purpose of this paper is to describe a new bioinformatic tool for use in psychiatric
research. The tool is called “SLEP” (Sullivan Lab Evidence Project) and is a searchable
archive of findings from psychiatric genetics that is freely available on the web for non-
commercial use (http://slep.unc.edu). SLEP is an example of “soft” bioinformatics: the use
of existing genomic data in the service of a biological problem (“hard” bioinformatics is
more concerned with novel algorithms or querying genomes in order to generate new
hypotheses).
Motivation
The motivation for creating SLEP is that findings from psychiatric genetic studies are
difficult to use and to contextualize. As a consequence, potentially useful and important
findings may be lost. There are a relatively large number of genomewide linkage (GWL),
genomewide association (GWA), and microarray (MA) studies and even a cursory summary
of findings for one disorder (much less across several disorders) is quite challenging. For
example, which linkage studies for what disorders provide support for NRG1? Or, what
GWA studies implicate rs4680 (the widely-studies val-met SNP in COMT)? In a practical
manner, these questions are very hard for most psychiatric geneticists to address and even
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more difficult for researchers from other disciplines who wish to make use of the
accumulated results from genetic investigations of psychiatric disorders.
Focus on evidence
The intention of SLEP is to supply evidence in support of a particular gene, marker, or
genomic region collated from unbiased empirical searches of the genome (i.e., genomewide
linkage or genomewide association studies) or the transcriptome (i.e., microarray studies)
for a set of core psychiatric disorders. As such, SLEP is not a meta-analytic tool. The
reasons why SLEP is a qualitative and not a quantitative tool are threefold. First, meta-
analysis requires access to the findings for all genetic markers investigated (and preferably
to individual genotype and phenotype data). Until quite recently, these data were not
routinely available and the predominant practice in the field was to publish only the findings
for the best markers. Second, comparison of data across study types — e.g., GWL with
GWA results — is complex and not readily handled in the absence of extensive data. Third,
our aim was to create a way to explore and synthesize findings from the literature and the
only practical solution was via a qualitative interface.
Results obtained from searches of the SLEP database will certainly contain false positive
findings. This approach is appropriate if the literature is viewed as being populated by
under-powered studies and if and “hits” from a SLEP search are viewed as “tentative
knowledge” (Ioannidis 2006) requiring rigorous experimental confirmation. Even with this
important limitation, SLEP can be of considerable utility in attempts to place an empirical
finding in the context of prior studies.
Study technologies
The single greatest advantage of modern human genetic approaches to the etiology of
complex traits is in their ability to uncover new and previously unsuspected etiological
factors for a disease. They do this by proving an unbiased screen of the relevant search space
(the genome and the transcriptome). Thus, the focus of SLEP is on three main study
technologies — GWL, GWA, and MA studies. Study technologies available in SLEP are
thus mixed — searches for DNA-level genomic variation along with searches for RNA-level
changes in transcript levels predisposing or protecting against a disorder. However, these
study types have in common their use of an unbiased exploration of the genomic or
transcriptomic search space.
Publication identification and review
The disorders currently contained in SLEP are attention-deficit hyperactivity disorder
(ADHD), autism (AUT), bipolar disorder (BIP), eating disorders (ED), major depressive
disorder (MDD), nicotine dependence (ND), and schizophrenia (SCZ), and we hope to
expand this list in the near future.
There were multiple steps involved in creating the SLEP database. (1) All relevant primary
studies were identified via overlapping PubMed (Wheeler and others 2006) searches
augmented by review of citation lists. All studies with a genomewide focus (excluding
studies limited to a chromosomal region or candidate genes), sufficient descriptive
information, and clear phenotype designations were included. (2) Where available, the most
comprehensive quantitative meta-analysis for each disorder was also included. (3) Two
reviewers independently abstracted information from each published report with any
disagreements resolved by discussion. The data abstracted were of two types — study meta-
data (study citation, technology, disorder, number of subjects, etc) and results (marker or
gene name, statistical test, and p-value). (4) Given the lack of widespread adherence to
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presentation standards in this area, a number of decisions were required in regard to which
publications and sets of results to include. (a) One report per sample was included. If there
were multiple reports from the same sample, the most comprehensive report was abstracted.
(b) One set of results was abstracted per report. As there were usually multiple choices, the a
priori decisions for SLEP were to select:
i. The initial Stage 1 genomewide findings and not analyses of more markers (i.e.,
fine-mapping) or secondary analyses (e.g., stratified or sex-specific analyses). The
intention here was to capture the initial, unbiased representation of the genome or
transcriptome screen before complicated by secondary analyses or fine-mapping
genotyping.
ii. The narrowest phenotypic definition per sample was used. Many studies presented
results for multiple phenotypic definitions (e.g., narrow, intermediate, and broad
definitions of affection for SCZ) and the narrowest was generally the one that
conformed most closely to DSM/ICD definitions of illness and are the most likely
to be comparable across studies. The exceptions to this were for AUT (given our
group’s interest in the broad AUT phenotype), eating disorders (because of a
paucity of studies), and smoking behavior (due to phenotypic inconsistencies across
studies).
iii. If multiple sets of initial analyses were presented (e.g., singlepoint, multipoint, non-
parametric linkage, parametric linkage, etc.), a single set was chosen with a
preference for multipoint, non-parametric results for GWL studies and Cochran-
Armitage trend test for GWA studies.
iv. Filters were applied in order to select results for inclusion in the SLEP database.
For GWL studies, markers with non-parametric LOD scores ≥ 1.5 were selected.
For GWA studies, single nucleotide polymorphisms with p-values < 0.05 were
included. To account for linkage disequilibrium, we used the “--clump” feature in
PLINK (Purcell and others 2007) to compress individual SNP findings with p <
0.001 to genomic segments with high linkage disequilibrium patterns with
reference to the appropriate HapMap panel (Frazer and others 2007). The focus on
genomic segments that take into account linkage disequilibrium is a more useful
portrayal of results and is considerably more compact. Finally, for MA studies, all
transcripts with significant differences at the 0.05 level were selected.
Database creation
Once the findings were accurately entered, a custom SAS (SAS Institute Inc. 2004) program
was used to create a series of data files. As part of this process, results specific to a marker
were placed on the NCBI Build 35 human genome assembly (Wheeler and others 2006),
also known as UCSC build hg17 (Hinrichs and others 2006). The data files were imported
into a relational database which served as the back-end data system for the application. A
custom, web-based user-interface was developed to enable users to search the findings based
on a variety of criteria. The core application was built entirely upon an open-source
framework (LAMP), written in PHP, backed by mySql, and employs AJAX technologies for
seamless interaction between the user, the web browser and the database.
Signposts
A potentially useful feature of SLEP is the inclusion of genomic “signposts”. These are a
conglomerate of findings from human genetics that can be searched along with the
psychiatric genetics literature. These data attempt to provide information about the genome
that might prove useful. We hope to include as much reliable genomewide data as possible.
The signpost dataset includes:
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i. Over 3,700 gene entries in the Online Mendelian Inheritance in Man (OMIM)
(McKusick 2007) that can be mapped to hg17 (e.g., GABRA1 and juvenile
myoclonic epilepsy).
ii. A manually curated list of confirmed associations from complex human diseases
(e.g., FTO- body mass index, PPARG-type 2 diabetes mellitus, and a copy number
variant on 16p11.2-autism).
iii. Genes for which a SNP is associated with expression differences in human cortex
(Myers and others 2007).
iv. Genes with evidence of imprinting (Luedi and others 2007)
v. Genes with evidence of selection from a genomic perspective (Sabeti and others
2007).
vi. Genes with evidence of monoallelic expression from a genomic survey (Gimelbrant
and others 2007).
vii. Genes commonly mutated in colon and breast cancer from a genomic survey
(Wood and others 2007).
viii. Over 10,300 copy number variants and 77 inversions from the Database of
Genomic Variants (Iafrate and others 2004).
ix. Genomic features such as persistent sequencing gaps, heterochromatin,
centromeres, telomeres, and the pseudo-autosomal regions (Hinrichs and others
2006).
Querying SLEP
The database can be queried in four ways — by gene name, SNP or microsatellite marker,
chromosome band (e.g., 22q11), or chromosome region (e.g., chr1:12,000,000-13,500,000).
The SLEP interface has one tab for each of these query methods. Gene name queries require
standard HUGO gene names (http://www.genenames.org/cgibin/hgnc_search.pl) (Eyre and
others 2006) and there is a lookup facility for common aliases. There are over 43,000
overlapping entries in the gene name database for all RefSeq (Pruitt and others 2005) and
KnownGenes (Hsu and others 2006). The marker data base contains over 422,000
microsatellite markers (many known by several names) along with 11.9 million SNPs
adapted from the TAMAL database (Hemminger and others 2006).
Users can modify their queries in several ways. First, the search can be for primary studies
and/or meta-analyses. Second, the search can be for any or all of the psychiatric disorders
currently in the SLEP database. Third, the user can select the technology used, i.e., GWL,
GWA, and/or MA studies (for convenience, the signpost database is included here as well).
Fourth, all searches can be widened by a specific number of kilobases or megabases in order
to accommodate differences in localization for each technology. Linkage analysis is known
to be imprecise and a linkage peak can be megabases from the true genomic variant.
Association analysis is known to be more precise in outbred human populations but its
precision is limited by local patterns of linkage disequilibrium. MA studies are, at least in
theory, the most precise as an altered transcript should be exactly identified.
The computer algorithm for processing SLEP queries has the following steps:
i. All types of queries are converted chrN:start-end coordinate format with reference
to the appropriate hg17 files.
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ii. The query is expanded by the number of bases specified by the user which may
vary by methodology. The defaults are 10 megabases for GWL, 5 kilobases for
GWA, 0 bases for MA, and 0 bases for signposts.
iii. The search is performed. For the expanded genomic region specified by the user,
SLEP identifies empirical findings that match all of the following criteria: the type
of study selected (primary report and/or meta-analysis), the disorder selected
(ADHD, AUT, BIP, EDs, MDD, ND, SCZ, and/or SCZ/BIP), and the study
methodology (GWL, GWA, MA, and/or signposts).
Output
SLEP returns a listing of all study findings on the web page below the user query. Basic data
about each hit are shown by default, and additional study metadata are optionally available
(e.g., definition of affection, diagnostic criteria, sample size, etc.). The user can request that
SLEP open a new web page with the study search and results displayed as custom
annotation tracks on the UCSC genome browser in order to access the wealth of genomic
data available there. Third, the results of a query can be downloaded as a comma-separated
value file (.csv) in order to be imported into a spreadsheet or some other program.
Example
An example of a SLEP search is depicted in Figure 1. Bullet a shows the four ways in which
SLEP can be searched. This example is a search by “Gene Name” for “comt” (bullet b).
Clicking on either of the lookup options opens a window to assist in finding the correct
standard gene name. Bullet c shows the three classes of options that can be used to fine-tune
a search (checking a box means to include studies matching that criterion). The type of study
can include primary reports and/or meta-analyses. Which psychiatric disorders included can
be modified to suit the purpose of the search (here, all are selected). The technology used
can be specified — i.e., GWL, GWA, or MA empirical studies along with the curated
“signpost” list described above. Each of these can be given an optional but different number
of bases by which to expand the query given the varying precision of these technologies.
A portion of the search results are shown next to bullet d (in this instance, a 2003 SCZ GWL
by Williams et al.). There are hyperlinks to download the search results to a comma-
separate-value text file (.csv), to show more information about each study, and to view the
results in the UCSC genome browser (bullet e). The topmost track in the UCSC browser
shows the location of the user query followed by the expanded extent of GWL, GWA, MA,
and “signpost” approaches. These are followed by additional tracks depicting the hits for the
specific search from the SLEP database. All other tracks normally available on the UCSC
genome browser can be viewed according to the user’s preference.
Conclusions
SLEP is a tool for searching and integrating findings from psychiatric genetics research. The
user interface is simple, flexible, and powerful. The SLEP database will be updated
approximately quarterly in order to integrate new findings from the upcoming generation of
GWA studies. It must be emphasized that SLEP searches are likely to contain false positive
findings. This is done by design given that limited power is a serious concern for most
psychiatric genetic studies. Separating true positive from false positive findings is a complex
empirical exercise. However, SLEP can be of considerable utility in attempts to place a new
empirical finding in the context of prior studies.
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Example of a SLEP search for the gene “COMT”. See text for full description.
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